Table 2 Baseline characteristics of included studies
Study ID | Study groups | Sample size | Age mean (SD) | Gender male (%) | Bmi mean (SD) |
|---|---|---|---|---|---|
Pimentel 2022 | Immunonutrient enriched supplement | 21 | 41.1 (2.8) | 14 (66.7) | 27.3 (1.2) |
control group (non-immunonutrient enriched supplement) | 22 | 41.9 (2.6) | 12 (54.5) | 27.8 (1) | |
Sedighiyan 2021 | Omega-3 + hydroxychloroquine | 15 | 66.46 (2.8) | 9 (60) | 27.01 (0.94) |
Control group (hydroxychloroquine alone) | 15 | 67.06 (2.28) | 9 (60) | 26.13 (0.73) | |
Kosmopoulos 2021 | Icosapent ethyl | 50 | 44 (16.29) | 24 (48) | 24.83 (3.33) |
Control group | 50 | 40.66 (17.77) | 21 (42) | 24.36 (4.22) | |
Doaei 2021 | 1000Â mg omega-3 | 28 | 66 (14.58) | 15 (53.6) | 27.68 (7.54) |
Control group | 73 | 64 (14.25) | 45(61.6) | 27.39 (3.15) |